Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Clinical Hypertension (Greenwich, Conn.)|September 24, 2016
Effects of Treating Primary Aldosteronism on Renal FunctionBart J Kramers, Cornelis Kramers, Jacques W M Lenders, et al.BMC Nephrology|July 5, 2018
Case report: a thiazide diuretic to treat polyuria induced by tolvaptanBart J Kramers, Maatje D A van Gastel, Esther Meijer, et al.Clinical Kidney Journal|December 24, 2021
The association of glucagon with disease severity and progression in patients with autosomal dominant polycystic kidney disease: an observational cohort studyMartine G E Knol, Bart J Kramers, Ron T Gansevoort, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 23, 2018
Determinants of Urine Volume in ADPKD Patients Using the Vasopressin V2 Receptor Antagonist TolvaptanBart J Kramers, Maatje D A van Gastel, Wendy E Boertien, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 7, 2023
Effects of salt and protein intake on polyuria in V2RA-treated ADPKD patientsPaul Geertsema, Iris W Koorevaar, Karin J R Ipema, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 5, 2020
Thiazide diuretics and the rate of disease progression in autosomal dominant polycystic kidney disease: an observational studyBart J Kramers, Iris W Koorevaar, Rudolf De Boer, et al.Clinical Journal of the American Society of Nephrology : CJASN|August 14, 2023
Prostaglandin E2, Osmoregulation, and Disease Progression in Autosomal Dominant Polycystic Kidney DiseaseFrank Geurts, Laixi Xue, Bart J Kramers, et al.Kidney International|June 14, 2020
Salt, but not protein intake, is associated with accelerated disease progression in autosomal dominant polycystic kidney diseaseBart J Kramers, Iris W Koorevaar, Joost P H Drenth, et al.Journal of Clinical Medicine|June 5, 2019
Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System InhibitorsMie K Eickhoff, Claire C J Dekkers, Bart J Kramers, et al.Clinical Journal of the American Society of Nephrology : CJASN|March 22, 2022
Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD: A Randomized Crossover TrialBart J Kramers, Iris W Koorevaar, Maatje D A van Gastel, et al.Pageof 2